CenterWatch

Clinical Trial Details

NCT ID: NCT01499433
Date Last Changed: January 22, 2014

Overview

Research Study Summary

Patients are needed to participate in a clinical research study of caspofungin to evaluate Invasive Pulmonary Aspergillosis or Chronic Obstructive Pulmonary Disease

Research Study Title

Prospective, Open-label Study of the Efficacy and Safety of Caspofungin for the Treatment of Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease

Purpose

The investigators propose to study the efficacy and safety of three-week antifungal therapy with caspofungin in hospitalized patients with proven or probable IPA underlying chronic obstructive pulmonary disease.

To Learn more

Recruitment Details

Phase
4
Gender
Both Male and Female
Age
18 and up
Overall Status
Recruiting
Lead Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Duration
32 Months
Facility Type
N/A
Compensation

Eligibility

Both Male and Female ages 18 Years and up

Inclusion Criteria:

  • Proven invasive pulmonary aspergillosis

  • Probable invasive pulmonary aspergillosis

  • Hospitalized in respiratory wards

  • Not having received an empirical antifungal therapy for 72h before inclusion

Exclusion Criteria:

  • A history of allergy to echinocandins

  • Severe renal failure, severe hepatic insufficiency

  • Inadequately treated bacterial infection

  • Documented HIV infection

  • Status of pregnancy or lactation

Site Locations (1)

Country State City Zip Facility and Contact
China Guangdong Guangzhou 510120 Guangzhou Institute of Respiratory Diseases
Nanshan Zhong, MD
862083062888
Nanshan@vip.163.com

Feng Ye, MD
Principal Investigator

Contact

Feng Ye, MD
862083062836
E-mail:

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.